AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

NULL
   
  • Closing Price Chg:
    340.00p
  • 52 Week High: NUL
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 0
  • RiskGrade: 123
  • Beta: 0.01

Latest ShareCast News

London close: Stocks mixed on corporate updates, trade developments

By Josh White

Date: Tuesday 29 Jul 2025

(Sharecast News) - London stocks ended Tuesday on a mixed note as a wave of corporate results kept investors busy and market participants continued to assess the implications of the recent US-EU trade deal.

AstraZeneca ShareCast News

Astrazeneca H1 gross profits up 10pc as 'strong ... 29-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
AstraZeneca reports positive results from autoim... 24-Jul-2025 ShareCast
AstraZeneca to invest $50bn in US manufacturing ... 22-Jul-2025 ShareCast
London close: Stocks fall after rise in UK consu... 16-Jul-2025 ShareCast

AstraZeneca Regulatory News

H1 and Q2 2025 results 29-Jul-2025 07:00 RNS
Gefurulimab nanobody met Phase III endpoints 24-Jul-2025 07:00 RNS
AstraZeneca plans to invest $50bn in the US 22-Jul-2025 07:00 RNS
Update on anselamimab in AL amyloidosis 16-Jul-2025 07:00 RNS
Baxdrostat met primary endpt in BaxHTN PhIII trial 14-Jul-2025 07:00 RNS

AstraZeneca Newspaper Links

AstraZeneca to invest $50bn in United States 22-Jul-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 340.00p
% Change 0.00 %
52 Week High NUL
52 Week Low 9,667.00p
Volume 0
Shares Issued 1,550.67m
Beta 0.01
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.24% below the market average94.24% below the market average94.24% below the market average94.24% below the market average94.24% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average
Price Trend
6.45% above the market average6.45% above the market average6.45% above the market average6.45% above the market average6.45% above the market average
28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average
Income
66.9% below the market average66.9% below the market average66.9% below the market average66.9% below the market average66.9% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.40% above the market average87.40% above the market average87.40% above the market average87.40% above the market average87.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page